Treating Methamphetamine Addiction in Oklahoma

If you’ve been waiting for a doctor to hand you a prescription that makes meth cravings disappear the way Suboxone can quiet opioid cravings, here’s the truth you deserve to hear plainly: that prescription doesn’t exist yet. There are currently no government-approved medications to treat methamphetamine addiction ¹. Not one.

That can land hard, especially if you’ve watched friends or family stabilize on medication for opioid or alcohol use disorder and wondered why there’s nothing like that for you.

But here’s the part that matters more. The Oklahoma State Department of Health, in the same breath that acknowledges the medication gap, says this: methamphetamine addiction is treatable, and behavioral therapies can help people stop using and recover ¹. The leading clinical guideline for stimulant use disorder says the same, and goes further — it recommends that structured behavioral treatment be the primary component of care, with co-occurring psychiatric conditions treated at the same time ⁷.

So the absence of a pill isn’t a dead end. It’s a signpost pointing you toward the kind of care that actually moves the needle for stimulant addiction: steady, structured, human work with people who know how to do it.

You may have read something online about a medication combination for meth and felt a flicker of hope. That study is real, and it’s worth understanding honestly instead of through a headline.

It’s called the ADAPT-2 trial — a multisite, double-blind randomized study of extended-release injectable naltrexone paired with oral extended-release bupropion in adults with moderate or severe methamphetamine use disorder. In the first stage, 16.5% of participants on the naltrexone-bupropion combination responded, compared with 3.4% on placebo. Across both stages, the weighted average response rate was 13.6% versus 2.5% ¹⁰.

Read that again. The medication helped roughly one in seven people meet the response criteria. That’s a real signal, and for the people it helped, it mattered. It’s also not a cure, and it isn’t FDA-approved for methamphetamine use disorder ¹⁰. Some clinicians use it off-label in carefully monitored settings as one piece of a larger plan.

So if a program ever tells you a medication alone will carry you through meth recovery, be skeptical. The honest version is that medication, if it’s part of your plan at all, is a small assist. The behavioral work is the engine.

If you’ve only heard of contingency management in passing, here’s the plain version: you get a small, tangible reward — a gift card, a voucher, a prize draw — every time a drug test confirms you haven’t used. That’s it. It sounds almost too simple to matter. The research says otherwise.

The ASAM/AAAP clinical practice guideline for stimulant use disorder is direct about this. It says contingency management should be a primary component of the treatment plan, used alongside other psychosocial treatments ⁷. A separate systematic review of non-pharmacological interventions for methamphetamine use disorder reached the same conclusion — behavioral treatment belongs in the first-line slot, and CM showed the strongest evidence of the approaches reviewed ⁹.

Why does something so small work? Meth hijacks the brain’s reward system. CM gently rebuilds a different reward signal: show up, test negative, feel something good that isn’t the drug. Over weeks, that rewiring starts to hold.

SAMHSA now allows approved grant-funded programs to offer motivational incentives of up to $750 per patient per year, with specific safeguards around rapid, FDA-approved point-of-care testing and immediate incentive delivery after a negative result ⁶. If you’re evaluating a program, it’s a fair question to ask: do you use contingency management, and how is it structured?

Contingency management gets you through the first stretch. Cognitive behavioral therapy and trauma-focused work are what help you build a life that doesn’t need meth in it.

CBT, in practice, is less about talking in circles and more about learning your own patterns. What time of day do cravings hit hardest? Who do you call when you’re bored, or lonely, or ashamed? What thought — usually a quick, almost invisible one — happens right before you reach for the drug? A systematic review of cognitive and behavioral therapies for people who use methamphetamine found that CBT was associated with reductions in methamphetamine use and other positive changes ⁸. That’s not a cure claim. It’s an honest signal that the work moves the needle.

Trauma-focused care matters because, for a lot of people, meth was never only about meth. It was about outrunning something — a childhood that wasn’t safe, a loss nobody helped you grieve, a body that stopped feeling like yours. The ASAM/AAAP guideline specifically recommends trauma screening using a trauma-sensitive approach, and treating co-occurring psychiatric conditions concurrently rather than one at a time ⁷.

At Country Road Recovery Center, this is where the clinical programming lives — CBT, DBT, trauma-focused therapy, and experiential modalities like equine and art therapy that let people process things their words can’t yet reach. If a program only talks about meth and not about what’s underneath it, that’s a gap worth noticing.

You deserve to hear the uncomfortable part too.

A 2024 systematic review and network meta-analysis looked at 72 randomized trials involving 6,836 participants and compared pharmacological, psychosocial, and harm-reduction interventions for amphetamine and methamphetamine use disorders. Its conclusion was sobering: no intervention showed moderate- or high-certainty evidence of important change across patient-important outcomes ¹¹.

Read carefully, that doesn’t mean nothing works. The ASAM/AAAP guideline still recommends CM as a primary component, and systematic reviews still support CBT and multimodal behavioral care as first-line treatment ^{7, 9}. What the meta-analysis is really saying is that the evidence base is heterogeneous, the studies are often small, and no single approach is a guaranteed answer for every person.

That’s actually why individualized, multimodal care matters so much here. There is no one lever to pull. The programs that help people recover from meth tend to be the ones that layer approaches — CM, CBT, trauma work, psychiatric care, peer support, aftercare — and adjust them to the specific person sitting in the room.

If the idea of “residential treatment” still sounds vague or vaguely scary, it helps to picture an actual day.

Country Road Recovery Center sits on 136 acres in Pink, Oklahoma, between Shawnee and Oklahoma City. The physical distance from wherever you’ve been using matters more than it sounds. You wake up somewhere quiet. There are horses. There’s a dining hall instead of a gas station at 3 a.m. The scenery alone is doing some of the work before the clinical day even starts.

The clinical day itself is structured, because structure is part of what Oklahoma requires. State rules define residential SUD treatment as a 24-hour-a-day, seven-day-a-week program of professionally directed evaluation, care, and treatment, with physician availability by phone around the clock ¹³. In practice, that translates to mornings anchored by group therapy, individual sessions through the week with a primary therapist, psychiatric check-ins when they’re needed, and afternoons that mix clinical work with the experiential pieces — equine therapy, art therapy, meditation, time outside.

Meals are shared. Sleep is protected, which is no small thing when meth has stolen it for months. The staff you’ll see most often includes people in long-term recovery themselves, so when you talk about the crash, or the shame, or the 2 a.m. craving, you aren’t explaining it to someone who only read about it.

A day in residential care isn’t dramatic. That’s the point. It’s boring in the healing way.

Here is where a lot of programs quietly fall short, and where it’s worth paying close attention.

Meth is rarely sitting there alone. For most people who end up in residential care, there’s a second story running underneath — untreated depression, anxiety that never got named, PTSD from something nobody helped you process, a brain that’s been managing itself with stimulants because nothing else quieted the noise. The ASAM/AAAP clinical practice guideline is explicit that stimulant use disorder and co-occurring psychiatric disorders should be treated concurrently, and that trauma screening belongs in care from the beginning, delivered in a trauma-sensitive way ⁷.

This is what dual diagnosis actually means at Country Road. The clinical programming layers CBT and DBT with trauma-focused therapy, and pairs those with experiential modalities — equine work, art, meditation, swimming — that give people ways to process things their words haven’t caught up to yet. Psychiatric evaluation is part of intake, not an afterthought. If depression or anxiety or trauma symptoms show up, they get treated as part of the same plan, not punted to “after you finish rehab.”

If you’re interviewing programs, ask directly: how do you treat the meth use and the mental health piece at the same time? The answer tells you almost everything.